Abstract:We paid attentions on recently published paper by Lei and colleagues [ [1] Lei Y. Yang G. Hu L. et al. Increased dipeptidyl peptidase-4 accelerates diet-related vascular aging and atherosclerosis in ApoE-deficient mice under chronic stress. Int. J. Cardiol. 2017 Sep 15; 243: 413-420 Abstract Full Text Full Text PDF PubMed Scopus (53) Google Scholar ]. The authors highlighted that DDP-4 inhibition with anagliptin contributed to atherosclerotic resistance. Intriguingly, the protective roles of DPP-4 inhibition during high glucose(HG)-/oscillating glucose(OG)-caused metabolic memory (MM) expanded their therapeutic effects [ 2 Sala L.L. Genovese S. Ceriello A. Effect of vildagliptin, compared to sitagliptin, on the onset of hyperglycemia-induced metabolic memory in human umbilical vein endothelial cells. Cardiovasc. Pharm. Open Access. 2017; 6: 203https://doi.org/10.4172/2329-6607.1000203 Crossref Google Scholar , 3 Pujadas G. De Nigris V. Prattichizzo F. et al. The dipeptidyl peptidase-4 (DPP-4) inhibitor teneligliptin functions as antioxidant on human endothelial cells exposed to chronic hyperglycemia and metabolic high-glucose memory. Endocrine. 2016; 56: 509-520 Crossref PubMed Scopus (43) Google Scholar ]. It has been commonly indicated that early HG or OG was remembered despite tight glucose control on micro-/macro-vasculature that referred to MM [ 4 Schisano B. Tripathi G. McGee K. et al. Glucose oscillations, more than constant high glucose, induce p53 activation and a metabolic memory in human endothelial cells. Diabetologia. 2011; 54: 1219-1226 Crossref PubMed Scopus (132) Google Scholar , 5 Chen J. Zhang J. Yang J. et al. Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats. Atherosclerosis. 2017; 257: 152-163 Abstract Full Text Full Text PDF PubMed Scopus (33) Google Scholar ], and the mechanisms complied with persistent epigenetic modification [ 4 Schisano B. Tripathi G. McGee K. et al. Glucose oscillations, more than constant high glucose, induce p53 activation and a metabolic memory in human endothelial cells. Diabetologia. 2011; 54: 1219-1226 Crossref PubMed Scopus (132) Google Scholar , 5 Chen J. Zhang J. Yang J. et al. Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats. Atherosclerosis. 2017; 257: 152-163 Abstract Full Text Full Text PDF PubMed Scopus (33) Google Scholar ]. Although our prior studies suggested that targeting histone demethylase KDM3A might limit MM-induced constant vascular remodeling [ [5] Chen J. Zhang J. Yang J. et al. Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats. Atherosclerosis. 2017; 257: 152-163 Abstract Full Text Full Text PDF PubMed Scopus (33) Google Scholar ], there existed great differences to transfer above achievements onto clinical trials. Response to letter “DPP-4 inhibition as a therapeutic strategy to ameliorate diabetic metabolic memory”International Journal of CardiologyVol. 256PreviewRecently, we have published our work entitled “Increased dipeptidyl peptidase-4 accelerates diet-related vascular aging and atherosclerosis in apolipoprotein E-deficient mice under chronic stress” [1]. In our study, anagliptin ameliorated harmful changes in plasma dipeptidyl peptidase-4 (DPP4), glucagon-like protein-1 (GLP-1), and adiponectin and decreased the parameters of inflammatory response and oxidative stress and proteolysis in the plaques of the stressed mice, suggesting that the ability of DPP4 inhibition to lessen over-activated inflammation, oxidative stress production and proteolysis may have a salutary effect on vascular damage under stress conditions through GLP-1-mediated adiponectin production in apolipoprotein E-deficient (ApoE−/−) mice fed high fat-diet. Full-Text PDF

DPP-4 Inhibitor Improved the Cognitive Function in Diabetic Rats

DPP-4 Inhibitors Suppress Tau Phosphorylation and Promote Neuron Autophagy through the AMPK/mTOR Pathway to Ameliorate Cognitive Dysfunction in Diabetic Mellitus

Dipeptidyl peptidase-4 inhibitors alleviate cognitive dysfunction in type 2 diabetes mellitus

Quercetin Improves Glucose and Lipid Metabolism of Diabetic Rats: Involvement of Akt Signaling and SIRT1

Dipeptidyl Peptidase IV(DPP IV): a Novel Emerging Target for the Treatment of Type 2 Diabetes

Restoring Brain Pathways Involved in Diabetes-Associated Neurocognitive Disorders: The Potential of Dipeptidyl Peptidase 4 Inhibitors as a Therapeutic Strategy

Can dipeptidyl peptidase-4 inhibitors treat cognitive disorders?

Neuroprotective effects of dipeptidyl peptidase 4 inhibitor on Alzheimer's disease: a narrative review

DPP-4 inhibition by linagliptin ameliorates age-related mild cognitive impairment by regulating microglia polarization in mice

Effects of DPP4 Inhibitors as Neuroprotective Drug on Cognitive Impairment in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis and Systematic Review

DPP-4 Inhibition As a Therapeutic Strategy to Ameliorate Diabetic Metabolic Memory.

A Novel Thiazolidinediones ATZD2 Rescues Memory Deficits in a Rat Model of Type 2 Diabetes Through Antioxidant and Anti-Inflammation

Dapagliflozin improves diabetic cognitive impairment via indirectly modulating the mitochondria homeostasis of hippocampus in diabetic mice

Daphnetin modulates GLP-1R to alleviate cognitive dysfunction in diabetes: implications for inflammation and oxidative stress

Trelagliptin relieved cognitive impairment of diabetes mellitus rats: Involvement of PI3K/Akt/GSK-3β and inflammation pathway

Betaine Alleviates Cognitive Deficits in Diabetic Rats via PI3K/Akt Signaling Pathway Regulation

Ameliorative Effects of Angiotensin-Iv on the Expression of Hippocampus Synaptophysin and the Cognitive Function of Diabetic Rats

Dipeptidyl Peptidase-4(Dpp-4) Inhibitors: Promising New Agents for Autoimmune Diabetes

PCSK9 inhibitor effectively alleviated cognitive dysfunction in a type 2 diabetes mellitus rat model

Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease.

Tirzepatide ameliorates spatial learning and memory impairment through modulation of aberrant insulin resistance and inflammation response in diabetic rats